LONP1
Lon protease homolog, mitochondrial
Also known as: hLON, LonHS, LONM_HUMAN, PIM1, PRSS15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P36776
- Gene
- LONP1
- Ensembl
- ENSG00000196365
- Chromosome
- 19
- Canonical length
- 959 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes a mitochondrial matrix protein that belongs to the Lon family of ATP-dependent proteases. This protein mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides in the mitochondrial matrix. It may also have a chaperone function in the assembly of inner membrane protein complexes, and participate in the regulation of mitochondrial gene expression and maintenance of the integrity of the mitochondrial genome. Decreased expression of this gene has been noted in a patient with hereditary spastic paraplegia (PMID:18378094). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2013]
Canonical amino-acid sequenceUniProt
959 residues, UniProt reviewed canonical sequence.
>P36776|LONP1
1 MAASTGYVRL WGAARCWVLR RPMLAAAGGR VPTAAGAWLL RGQRTCDASP PWALWGRGPA
61 IGGQWRGFWE ASSRGGGAFS GGEDASEGGA EEGAGGAGGS AGAGEGPVIT ALTPMTIPDV
121 FPHLPLIAIT RNPVFPRFIK IIEVKNKKLV ELLRRKVRLA QPYVGVFLKR DDSNESDVVE
181 SLDEIYHTGT FAQIHEMQDL GDKLRMIVMG HRRVHISRQL EVEPEEPEAE NKHKPRRKSK
241 RGKKEAEDEL SARHPAELAM EPTPELPAEV LMVEVENVVH EDFQVTEEVK ALTAEIVKTI
301 RDIIALNPLY RESVLQMMQA GQRVVDNPIY LSDMGAALTG AESHELQDVL EETNIPKRLY
361 KALSLLKKEF ELSKLQQRLG REVEEKIKQT HRKYLLQEQL KIIKKELGLE KDDKDAIEEK
421 FRERLKELVV PKHVMDVVDE ELSKLGLLDN HSSEFNVTRN YLDWLTSIPW GKYSNENLDL
481 ARAQAVLEED HYGMEDVKKR ILEFIAVSQL RGSTQGKILC FYGPPGVGKT SIARSIARAL
541 NREYFRFSVG GMTDVAEIKG HRRTYVGAMP GKIIQCLKKT KTENPLILID EVDKIGRGYQ
601 GDPSSALLEL LDPEQNANFL DHYLDVPVDL SKVLFICTAN VTDTIPEPLR DRMEMINVSG
661 YVAQEKLAIA ERYLVPQARA LCGLDESKAK LSSDVLTLLI KQYCRESGVR NLQKQVEKVL
721 RKSAYKIVSG EAESVEVTPE NLQDFVGKPV FTVERMYDVT PPGVVMGLAW TAMGGSTLFV
781 ETSLRRPQDK DAKGDKDGSL EVTGQLGEVM KESARIAYTF ARAFLMQHAP ANDYLVTSHI
841 HLHVPEGATP KDGPSAGCTI VTALLSLAMG RPVRQNLAMT GEVSLTGKIL PVGGIKEKTI
901 AAKRAGVTCI VLPAENKKDF YDLAAFITEG LEVHFVEHYR EIFDIAFPDE QAEALAVERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LONP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 190 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 190 nTPM
- liver: 76 nTPM
- heart muscle: 72 nTPM
- skeletal muscle: 65 nTPM
- choroid plexus: 62 nTPM
- basal ganglia: 46 nTPM
Single-cell type
- epicardial cells: 118 nCPM
- adrenal cortex cells: 85 nCPM
- oocytes: 83 nCPM
- hepatocytes: 59 nCPM
- alveolar cells type 2: 53 nCPM
- syncytiotrophoblasts: 49 nCPM
Immune cell
- basophil: 4.6 nTPM
- memory B-cell: 4 nTPM
- plasmacytoid DC: 3.9 nTPM
- naive CD4 T-cell: 3.8 nTPM
- intermediate monocyte: 3.7 nTPM
- naive B-cell: 3.7 nTPM
Brain region
- choroid plexus: 67 nTPM
- thalamus: 62 nTPM
- pons: 62 nTPM
- medulla oblongata: 59 nTPM
- cerebral cortex: 59 nTPM
- hypothalamus: 58 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LONP1.
Disease | AllUniProt
Conditions LONP1 is implicated in, by any mechanism.
- CODAS syndrome (CODASS) MIM:600373
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 1,169 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- CODAS syndrome
- LONP1-related disorder
- Epilepsy of infancy with migrating focal seizures
- See cases
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- -1.38
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to oxidative stress
- chaperone-mediated protein complex assembly
- mitochondrial protein catabolic process
- mitochondrion organization
- negative regulation of insulin receptor signaling pathway
- protein quality control for misfolded or incompletely synthesized proteins
- proteolysis involved in protein catabolic process
- response to aluminum ion
- response to hormone
- response to hypoxia
- oxidation-dependent protein catabolic process
Molecular functions
- ADP binding
- ATP binding
- ATP hydrolysis activity
- ATP-dependent peptidase activity
- DNA polymerase binding
- G-quadruplex DNA binding
- identical protein binding
- insulin receptor substrate binding
- PH domain binding
- sequence-specific DNA binding
- serine-type endopeptidase activity
- single-stranded DNA binding
- single-stranded RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lon protease, N-terminal domain
- AAA+ ATPase domain
- ATPase, AAA-type, core
- Lon protease, bacterial/eukaryotic-type
- Peptidase S16, active site
- Peptidase S16, Lon proteolytic domain
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- PUA-like superfamily
- Ribosomal protein uS5 domain 2-type superfamily
- Lon protease
- P-loop containing nucleoside triphosphate hydrolase
- Lon protease, N-terminal domain superfamily
- Lon protease, AAA+ ATPase lid domain
- ATPase family associated with various cellular activities (AAA)
- ATP-dependent protease La (LON) substrate-binding domain
- Lon protease (S16) C-terminal proteolytic domain
- Lon protease AAA+ ATPase lid domain
- Lon protease homologue, chloroplastic/mitochondrial
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LONP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LONP1 as an antibody target. Whether an autoantibody or antibody against LONP1 could matter depends on whether native LONP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LONP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LONP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...